[eDisclosure Notice] KOSDAQ - 8th

< Major Announcements After Market Close >

◆Hisonic=Submission of objection to the delisting review and resolution by the Korea Exchange KOSDAQ Market Committee

◆Genome&Company=Approval of IND for domestic Phase 2 clinical trial of microbiome immuno-oncology drug 'GEN-001'

◆Asia Economy=Change of largest shareholder from KMH and 2 others to Keystone Dynamic No.5 Investment Purpose Company

◆NSN=Advance notice of designation as an unfaithful disclosure company due to termination of single sales and supply contract

◆DSK=Subsidiary Protox decides on a 41.8 billion KRW rights offering to raise operating funds

◆SCM Life Sciences=Advance notice of designation as an unfaithful disclosure company due to delayed disclosure of major management matters related to investment decisions

◆Sejong Medical=Advance notice of designation as an unfaithful disclosure company due to withdrawal of rights offering decision

◆Semisysco=Designation as an unfaithful disclosure company due to reversal of 4 disclosures including withdrawal of rights offering decision. Suspension of stock trading on the 12th

◆UbioLogics=Change of largest shareholder from Kim Deok-sang and 7 others to Bionote and 2 others